Fierce Biotech: Digital Stethoscope Maker Eko Nets $65M To Develop Home Telehealth Offerings


Summary: The proceeds will be used to expand the use of Eko's devices and AI capabilities.
Fierce Biotech: Digital Stethoscope Maker Eko Nets $65M To Develop Home Telehealth Offerings

As the use of telehealth continues to surge-promising a way to deliver distanced care in spite of the coronavirus, and potentially a new normal in a post-pandemic world-the makers of a digital, connected stethoscope have raised new funds to expand its remote disease screening programs.

Eko secured $65 million in a series C venture capital round, led by Highland Capital Partners and Questa Capital, alongside additional backers in Artis Ventures, DigiTx Partners, NTTVC, 3M Ventures and other investors.

Read more at Fierce Biotech